SNMMI Image of the Year: Novel Immuno-PET Tracer Outperforms FDG PET in Predicting PD-L1 Expression in Head and Neck Cancer
A groundbreaking advancement in molecular imaging has recently emerged from the realm of nuclear medicine, promising to redefine how clinicians ...
![PD-L1 targeting molecular imaging in head and neck carcinoma: A head-to-head comparison of [18F]AlF-NOTA-PCP2 PET and [18F]FDG PET/CT.](https://scienmag.com/wp-content/uploads/2025/06/SNMMI-Image-of-the-Year-Novel-Immuno-PET-Tracer-Outperforms-FDG-350x250.jpeg)
